Glen Eagle Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,437
Closed -$28.8K 1006
2022
Q1
$28.8K Sell
1,437
-619
-30% -$12.9K 0.01% 458
2021
Q4
$52.1K Hold
2,056
0.01% 365
2021
Q3
$55.5K Hold
2,056
0.02% 359
2021
Q2
$59.5K Hold
2,056
0.02% 348
2021
Q1
$54.1K Hold
2,056
0.02% 333
2020
Q4
$58.9K Hold
2,056
0.02% 304
2020
Q3
$49K Buy
+2,056
New +$47.4K 0.02% 307

Other funds holding BMEZ

Glen Eagle Advisors's BMEZ Position: Q2 2022 in Review

Glen Eagle Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2022, closing a stake of 1,437 shares — an estimated $28.8K sold.

Glen Eagle Advisors first reported a position in BMEZ in Q3 2020 and held it in 7 quarters. The position peaked at $59.5K in Q2 2021. 78 funds tracked by Wall St. Rank hold BMEZ as of Q2 2022.

  • Glen Eagle Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q2 2022 after selling out during the quarter.
  • Glen Eagle Advisors sold 1,437 BlackRock Health Sciences Trust II shares in Q2 2022, an estimated $28.8K.
  • Glen Eagle Advisors first reported a position in BlackRock Health Sciences Trust II in Q3 2020 and held it in 7 quarters.
  • Glen Eagle Advisors's BlackRock Health Sciences Trust II position peaked at $59.5K in Q2 2021.
  • 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2022.

Based on Glen Eagle Advisors's 13F filing for Q2 2022, filed 13 Aug 2024.